Pearson’s correlation and Spearman’s correlation analyses were performed for the three groups of breast cancer patients, i.e., BRCA1-mutated, BRCA2-mutated, and ErbB2-amplified breast cancer patients, depending on the normal or non-normal distribution of expression data (Figure 6). Here, ERBB2 is linked to breast carcinoma.